Kuehn Law Encourages Investors of Akero Therapeutics, Inc. to Contact Law Firm

NEW YORK, Jan. 24, 2025 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Akero Therapeutics, Inc. (NASDAQ: AKRO) breached their fiduciary duties to shareholders. The investigation concerns potential self-dealing. Shareholders may be entitled to damages and corporate governance reforms.If you are a long-term AKRO stockholder please contact Justin Kuehn, Esq. here, by email at [email protected], or call (833) 672-0814. The consultat ...